Brandywine Trust’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $22.9M | Sell |
105,252
-4,771
| -4% | -$1.06M | 4.15% | 4 |
|
|
2025
Q4 | $25.1M | Sell |
110,023
-6,766
| -6% | -$1.54M | 4.41% | 4 |
|
|
2025
Q3 | $27M | Hold |
116,789
| – | – | 4.11% | 4 |
|
|
2025
Q2 | $21.7M | Hold |
116,789
| – | – | 3.31% | 4 |
|
|
2025
Q1 | $24.5M | Sell |
116,789
-4,800
| -4% | -$933K | 3.79% | 4 |
|
|
2024
Q4 | $21.6M | Sell |
121,589
-5,080
| -4% | -$934K | 3.41% | 4 |
|
|
2024
Q3 | $25M | Sell |
126,669
-5,277
| -4% | -$985K | 3.73% | 4 |
|
|
2024
Q2 | $22.6M | Hold |
131,946
| – | – | 3.76% | 4 |
|
|
2024
Q1 | $24M | Sell |
131,946
-2,800
| -2% | -$483K | 4.08% | 4 |
|
|
2023
Q4 | $20.9M | Sell |
134,746
-355
| -0.3% | -$51.8K | 4.2% | 4 |
|
|
2023
Q3 | $20.1M | Hold |
135,101
| – | – | 4.86% | 4 |
|
|
2023
Q2 | $18.2M | Hold |
135,101
| – | – | 4.01% | 4 |
|
|
2023
Q1 | $21.5M | Hold |
135,101
| – | – | 5.8% | 4 |
|
|
2022
Q4 | $21.8M | Hold |
135,101
| – | – | 6.66% | 2 |
|
|
2022
Q3 | $18.1M | Hold |
135,101
| – | – | 6.53% | 2 |
|
|
2022
Q2 | $20.7M | Hold |
135,101
| – | – | 7% | 2 |
|
|
2022
Q1 | $21.9M | Sell |
135,101
-10,000
| -7% | -$1.45M | 7.18% | 2 |
|
|
2021
Q4 | $19.6M | Hold |
145,101
| – | – | 6.6% | 3 |
|
|
2021
Q3 | $15.7M | Hold |
145,101
| – | – | 5.46% | 4 |
|
|
2021
Q2 | $16.3M | Hold |
145,101
| – | – | 5.17% | 3 |
|
|
2021
Q1 | $15.7M | Hold |
145,101
| – | – | 4.93% | 4 |
|
|
2020
Q4 | $15.5M | Sell |
145,101
-5,057
| -3% | -$486K | 5.42% | 2 |
|
|
2020
Q3 | $13.2M | Sell |
150,158
-10,885
| -7% | -$1.02M | 4.95% | 3 |
|
|
2020
Q2 | $15.8M | Hold |
161,043
| – | – | 5.42% | 2 |
|
|
2020
Q1 | $12.3M | Hold |
161,043
| – | – | 8.31% | 2 |
|
|
2019
Q4 | $14.3M | Hold |
161,043
| – | – | 8.22% | 3 |
|
|
2019
Q3 | $12.2M | Hold |
161,043
| – | – | 8.16% | 4 |
|
|
2019
Q2 | $11.7M | Hold |
161,043
| – | – | 8.27% | 4 |
|
|
2019
Q1 | $13M | Hold |
161,043
| – | – | 11.42% | 2 |
|
|
2018
Q4 | $14.8M | Sell |
161,043
-328
| -0.2% | -$28.8K | 14.4% | 1 |
|
|
2018
Q3 | $15.3M | Hold |
161,371
| – | – | 13.03% | 2 |
|
|
2018
Q2 | $15M | Sell |
161,371
-956
| -0.6% | -$93.4K | 13.02% | 2 |
|
|
2018
Q1 | $15.4M | Buy |
162,327
+956
| +0.6% | +$105K | 13.63% | 2 |
|
|
2017
Q4 | $15.6M | Hold |
161,371
| – | – | 13.25% | 2 |
|
|
2017
Q3 | $14.3M | Hold |
161,371
| – | – | 12.83% | 2 |
|
|
2017
Q2 | $11.7M | Sell |
161,371
-59,450
| -27% | -$4M | 12.3% | 4 |
|
|
2017
Q1 | $14.4M | Hold |
220,821
| – | – | 9.76% | 3 |
|
|
2016
Q4 | $13.8M | Sell |
220,821
-3,863
| -2% | -$236K | 9.41% | 4 |
|
|
2016
Q3 | $14.2M | Sell |
224,684
-171
| -0.1% | -$11.1K | 10.37% | 4 |
|
|
2016
Q2 | $13.9M | Buy |
224,855
+65,000
| +41% | +$3.96M | 9.31% | 4 |
|
|
2016
Q1 | $9.13M | Hold |
159,855
| – | – | 6.41% | 5 |
|
|
2015
Q4 | $9.47M | Hold |
159,855
| – | – | 7.45% | 5 |
|
|
2015
Q3 | $8.7M | Buy |
159,855
+2,520
| +2% | +$164K | 7.32% | 5 |
|
|
2015
Q2 | $10.6M | Hold |
157,335
| – | – | 7.28% | 4 |
|
|
2015
Q1 | $9.21M | Buy |
157,335
+840
| +0.5% | +$50.7K | 5.95% | 5 |
|
|
2014
Q4 | $10.2M | Hold |
156,495
| – | – | 9.42% | 4 |
|
|
2014
Q3 | $9.04M | Hold |
156,495
| – | – | 8.65% | 4 |
|
|
2014
Q2 | $8.83M | Hold |
156,495
| – | – | 10.73% | 4 |
|
|
2014
Q1 | $8.04M | Buy |
156,495
+540
| +0.3% | +$27.3K | 9.79% | 4 |
|
|
2013
Q4 | $8.24M | Hold |
155,955
| – | – | 10.23% | 4 |
|
|
2013
Q3 | $6.98M | Buy |
155,955
+38,400
| +33% | +$1.7M | 9.7% | 4 |
|
|
2013
Q2 | $4.86M | Buy |
+117,555
| New | +$5.14M | 7.02% | 5 |
|
Other funds holding ABBV
VCM
VPM
Brandywine Trust's ABBV Position: Q1 2026 in Review
Brandywine Trust reduced its AbbVie (ABBV) stake by 4.3% in Q1 2026, selling an estimated $1.06M and leaving 105,252 shares worth $22.9M. The position accounts for 4.15% of the portfolio, ranked #4.
Brandywine Trust first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $27M in Q3 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Brandywine Trust held 105,252 shares of AbbVie worth $22.9M as of Q1 2026.
- Brandywine Trust sold 4,771 AbbVie shares in Q1 2026, an estimated $1.06M.
- AbbVie made up 4.15% of Brandywine Trust's portfolio in Q1 2026, its #4 holding.
- Brandywine Trust first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- Brandywine Trust's AbbVie position peaked at $27M in Q3 2025.
- 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Brandywine Trust's 13F filing for Q1 2026, filed 14 May 2026.